Follicular lymphoma. High-dose immunochemotherapy with autologous blood stem cell transplantation: Results of the first prospective study in Russia-Reference-Cited by-同舟云学术

Follicular lymphoma. High-dose immunochemotherapy with autologous blood stem cell transplantation: Results of the first prospective study in Russia

Published:2016 Issue:7 Volume:88 Page:62
ISSN:0040-3660
Container-title:Terapevticheskii arkhiv
language:en
Short-container-title:Ter. arkh.

Author:

Nesterova E. S.,Kravchenko S. K.,Mangasarova Ya. K.,Baryakh E. A.,Misyurina A. E.,Vorobyev V. I.,Plastinina L. V.,Chernova N. G.,Kovrigina A. M.,Obukhova T. N.,Klyasova G. A.,Shevelev A. A.,Kostina I. E.,Gemdzhian E. G.,Gaponova T. V.,Vorobyev A. I.

Publisher

LLC Obyedinennaya Redaktsiya

Subject

General Medicine,Endocrinology, Diabetes and Metabolism,History,Family Practice

Reference35 articles.

1. Davydov M, Axel E. Statistics of malignant neoplasms in Russia and CIS countries in 2009. Moscow, Bulletin of N.N. Blokhin RONC Russian Academy of medical Sciences. 2011;22(1). (In Russ.)

2. Rummel MJ, Niederle N, Maschmeyer G, Banat GA, von Grünhagen U, Losem C, Kofahl-Krause D, Heil G, Welslau M, Balser C, Kaiser U, Weidmann E, Dürk H,Ballo H, Stauch M, Roller F, Barth J, Hoelzer D, Hinke A, Brugger W; Study group indolent Lymphomas (StiL). Bendamustine plus rituximab versus CHOP plus rituximab as fi rst-line treatment for patients with indolent and mantle-cell lymphomas: an open-label, multicentre, randomised, phase 3 non-inferiority trial. Lancet. 2013;381(9873):1203-1210.

3. Ladetto M, De Marco F, Benedetti F, Vitolo U, Patti C, Rambaldi A, Pulsoni A, Musso M, Liberati AM, Olivieri A, Gallamini A, Pogliani E, Rota Scalabrini D,Callea V, Di Raimondo F, Pavone V, Tucci A, Cortelazzo S, Levis A, Boccadoro M, Majolino I, Pileri A, Gianni AM, Passera R, Corradini P, Tarella C; Gruppo Italiano Trapianto di Midollo Osseo (GITMO); Intergruppo Italiano Linfomi (IIL). Prospective, multicenter randomized GITMO/IIL trial comparing intensive (R-HDS) versus conventional (CHOP-R) chemoimmunotherapy in high-risk follicular lymphoma at diagnosis: the superior disease control of R-HDS does not translate into an overall survival advantage. Blood. 2008;111:4004-4013.

4. Barr P. M., Lazarus H. M. Follicular non-Hodgkin lymphoma: long-term results of stem-cell transplantation. Curr Opin Oncol. 2008;20:502-508.

5. Metzner B, Pott C, Müller TH, Gebauer W, Casper J, Kraemer D, Rosien B, Schumann-Binarsch S, Thole R, Köhne CH. Long-term clinical and molecular remissions in patients with follicular lymphoma following high-dose therapy and autologous stem cell transplantation. Ann Oncol. 2013;24(6):1609-1615.

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Informativeness of whole-body diffusion-weighted magnetic resonance imaging and positron emission tomography with computed tomography in follicular lymphoma;Terapevticheskii arkhiv;2020-09-01

2. Follicular lymphoma: first - line selection criteria of treatment;Terapevticheskii arkhiv;2019-08-15

3. The role of translocations involving c-MYC/8q24, BCL2/18q21 and/or BCL6/3q27 genes in patients with follicular lymphoma. Retrospective analysis of single - centre data;Terapevticheskii arkhiv;2019-07-15

4. Follicular lymphoma: results of multicenter study of first-line therapy with bendamustine and rituximab, risk factors for adverse events (fl-rus-2013 protocol);Oncohematology;2018-10-27